“ "As the leader in our field, it is our mission to increase awareness; on the one hand, we recognize this as our responsibility and on the other… ”
In Conversation
“ "In the Philippines, we are organized in business units to allow us to focus on niche markets where we can gain market presence. The Women’s Health… ”
“ "For GE Healthcare Philippines, the priority is really developing our affordable care portfolio. Last year the ASEAN region was moved into a separated business group, which… ”
Interview: Bakhuti Shengelia – Director, Healthcare Systems, Novartis International AG, the Philippines
“ "Our approach to partnership starts with objective understanding of the challenges that governments and healthcare professionals face. We are trying to put ourselves in the shoes… ”
“ "In emerging markets such as the Philippines, there remains great opportunity to educate key stakeholders on the value of innovation. Often, access is equated to price." ”
Interview: Peter Ulvskjold – Corporate Vice President of International Operations, South East Asia, Novo Nordisk
“ "We work with patient organizations, endocrinology societies and government agencies that focus on chronic diseases. It is part of my responsibility to maximize the outcomes of… ”
Interview: Mary Harney – Chairperson of the European Steering Group (ESG) on Sustainable Healthcare, Ireland
“ "Healthcare in Ireland is very political. Even though we are a small country, people sometimes want their local hospitals to provide a complete package of specialist… ”
“ "Drugs are such delicate mechanisms and drug development is so fraught with risk and uncertainty and the inherent complexity and the volatility of the pharma industry… ”
“ Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through ”
“ "We want to reposition Biopôle as a life sciences ecosystem bringing together academia, business, and research; our aim is that there is no separation between research… ”
“ "Amneal is a highly diversified, global generics company, with products in the tablets, the oral doses, liquids, transdermals and OTC spaces. Now, we are looking to… ”
“ "For the past 17 months then, EirGen has been in a state of transformation. Our core business prior to the acquisition would have been as a… ”